INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2017

Combined chondroitin sulfate and glucosamine sulfate was not superior to placebo for knee osteoarthritis pain or functional impairment over 6 months.

A 6-month trial evaluated oral chondroitin sulfate (1,200 mg) plus glucosamine sulfate (1,500 mg) daily versus placebo in 164 patients with symptomatic knee osteoarthritis. In the modified intent-to-treat population, combination therapy was inferior to placebo for joint pain reduction (mean ± SEM change in VAS pain -11.8 ± 2.4 mm [19%] vs. -20.5 ± 2.4 mm [33%], between-group difference 8.7 mm, P < 0.03), though no difference was seen in per-protocol completers. Total WOMAC scores, WOMAC pain and function subscales, OMERACT-OARSI response rates, and rescue medication use did not differ between groups. Severe adverse events were uncommon and distributed equally.

Study type
Multicenter, randomized, double-blind, placebo-controlled trial
Who was studied
164 patients with Kellgren/Lawrence grade 2 or 3 radiographic knee osteoarthritis and moderate-to-severe knee pain
What was measured
Change from baseline in VAS global pain score, WOMAC scores, OMERACT-OARSI responder rates, and rescue medication use

THE PAPER

Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Roman-Blas JA, Castañeda S, Sánchez-Pernaute O, Largo R, Herrero-Beaumont G, CS/GS Combined Therapy Study Group. Arthritis Rheumatol, 2017.

PubMed 27477804 ↗DOI 10.1002/art.39819 ↗

Bones & muscles

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.